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Abstract 
 
Background:  Irritable Bowel Syndrome is a gastrointestinal disorder that is 
associated with pain, discomfort, constipation and diarrhoea. It affects around 20% of adults 
in Western countries. Reports of distress and self-consciousness, as well as experiential and 
situational avoidance are common. Previous studies have shown that ACT may be effective 
for people with IBS. 
 
Methods:  An uncontrolled trial of ACT based bibliotherapy was undertaken in a 
specialist motility clinic. Outcomes were measured with standardised self-report 
questionnaires pre-treatment, and at two and six months. Missing data was handled using 
maximum likelihood imputation. Data was analysed using repeated measures ANOVA.  
 
Results:   45 participants enrolled in the study, with 36 providing data at two 
months, and 24 at six months. Participants were predominantly female, with an average ten-
year history of IBS, and 71% of the sample had moderate or severe symptoms. At six 
months,participants had improved on symptom severity (hp2 = .09, 90% CI = .01 - .18), GI 
specific anxiety (hp2 = .07, 90% CI = .01 - .16) and IBS willingness (hp2 = .14, 90% CI = .04 - 
.24), but had not shown behavioural changes towards greater activity, (hp2 = .01, 90% CI = .0 
- .05) or to reduce IBS avoidance behaviours (hp2 = .05, 90% CI = .0 = .13). Contrary to 
hypothesis, intervention did not reduce the impact of IBS on quality of life(hp2 = .04, 90% CI 
= .0 - .09). 
 
Discussion:  Bibliotherapy interventions may be useful for people with refractory 
IBS, though greater contact and structured exposure may be necessary to change behaviour. 
The study was limited by problems with attrition, though these data suggest future research in 
this area would be worthwhile.     
 
 
Keywords: Irritable Bowel Syndrome, IBS, Acceptance & Commitment Therapy, ACT, 
Bibliotherapy, Self-Help.  
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Introduction 
 
IBS is a functional gastrointestinal disorder affecting around 10 – 20% of adults in Western 
countries, most of whom are female (Thompson, Irvine, Pare, Ferrazzi, & Rance, 2002; 
Wilson, Roberts, Roalfe, Bridge, & Singh, 2004). It is characterized by abdominal pain, 
bloating, discomfort and changes in bowel habit (Longstreth et al., 2006; Tanaka, Kanazawa, 
Fukudo, & Drossman, 2011). When symptoms remain after 12 months of pharmacological 
treatment, IBS is considered ‘refractory’ (NICE, 2008). People with IBS often report 
embarrassment and shame, and stop socialising, withdraw from intimacy, reduce working 
hours and reduce participation in normal community activities	(Rønnevig, Vandvik, & 
Bergbom, 2009; Schneider & Fletcher, 2008). IBS is associated with psychiatric disorder, 
with rates of 17% for major depression and 32% for generalised anxiety disorder (Lydiard, 
2001).  
 
Several psychological therapies have been trialled for IBS. Hypnotherapy and cognitive 
behavioural therapy (CBT) have the strongest evidence (Lee, Choi, & Choi, 2014; Li, Xiong, 
Zhang, Yu, & Chen, 2014). The focus of hypnotherapy is upon reduction of stress via 
relaxation and suggestion, leading to better symptom control (Whorwell, 2005; Webb, 
Kukuruzovic, Catto-Smith, & Sawyer, 2007). Recent meta analyses show hypnotherapy to be 
effective at short term, but the pattern of results is not conclusive as to the effects at follow-
up. In addition, mechanisms of action are unclear (Lee et al., 2014). 
 
In CBT for IBS, patients are educated about the physiological, cognitive, behavioural and 
emotional influences on their condition, and are taught self-control strategies to enhance 
coping behaviours, reduce stress and alter dysfunctional thinking about IBS. Meta-analyses 
have shown that CBT is effective for IBS, when compared to non-active controls, but not 
superior to standard medical care or basic support (Li et al., 2014; Lackner, et al., 2007).).  
 
CBT has been used to design self-help interventions for IBS. Hunt, Ertel, Coello, & 
Rodriguez (2015) reported benefits as did Sanders, Blanchard, & Sykes (2007), though 
attrition was high in both studies. Everitt, et al. (2010) found a web based self-help 
intervention to be comparable to medication, but neither outperformed a ‘no treatment’ 
control condition. 
 
What is shared in both CBT and hypnotherapy for IBS is a focus on gaining control over IBS 
symptoms. For many patients, not only does this strategy not reliably lead to symptom 
control, it has the unintended consequence of further restricting normal functioning (Ferreira, 
Eugenicos, Morris, & Gillanders, 2011). Acceptance and Commitment Therapy (ACT) 
(Hayes, Strosahl, & Wilson, 2012) challenges the need to use control-based strategies. 
Instead, client and therapist work together to construct overarching life goals, and 
behavioural strategies are used to move towards these goals. Mindfulness, acceptance and 
perspective taking skills are taught to facilitate goal oriented behaviour in the presence of 
difficult symptoms, thoughts and emotions; hence Acceptance and Commitment.  
 
ACT is effective for other long-term health conditions, including chronic pain (Graham, 
Gouick, Krahé, & Gillanders, 2016; Hann & McCracken, 2014) and there is preliminary 
evidence that ACT may be applicable to IBS. Whilst not described as ACT, Ljótsson et al. 
(2010, 2011) reported benefits of an internet delivered exposure and mindfulness treatment. 
Treatment was highly structured, was supported by an online peer chat room and 
asynchronous weekly therapist support. It used mindfulness to facilitate patients’ exposure to 
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avoided situations and sensations, whilst reducing control oriented behaviours. Large effect 
sizes were reported across measures of symptoms and quality of life, with gains maintained at 
15 to 18 month follow up (Ljótsson et al., 2011). Ljótsson and colleagues’ study reflected a 
trend within other areas of CBT to use principles such as exposure and mindfulness, without 
naming the intervention as ‘ACT’ (e.g. Arch & Craske, 2008). Such a strategy has allowed 
studies to remain identified with the broader CBT tradition whilst incorporating elements of 
the ‘third wave’. 
 
Finally, Ferreira, Gillanders, Morris, & Eugenicos (in press) reported a trial of ACT for IBS. 
Participants took part in a one-day group workshop, combined with a self-help book and 
audio CD to modify their approach to IBS (Ferreira & Gillanders, 2012). Ferreira and 
colleagues showed that participants’ acceptance of IBS increased, and that this mediated 
improvements in symptoms, stress, quality of life and avoidance behaviours.  
 
The current study aimed to extend Ferreira et al. (in press) by testing the impact of 
bibliotherapy alone. The primary outcome was the impact of IBS on quality of life. The book 
explicitly targeted avoidance and acceptance and so it was predicted that the intervention 
would lead to improvements in both. If participants began to live more effectively with IBS, 
improvements in gastrointestinal specific anxiety and IBS symptom severity were also 
predicted. These improvements were expected to be seen at the two-month assessment and to 
have continued to improve at the six-month follow up. 
 
Materials and Methods 
 
Design 
An uncontrolled implementation trial of self-help was conducted in a specialist motility 
clinic. Participants were new or return attenders who were diagnosed with refractory IBS by a 
consultant gastroenterologist with expertise in IBS (author M.E.), using ROME III criteria 
(Longstreth et al., 2006). Participants completed standardised self-report measures prior to 
intervention, at two months and six months later. The study was designed and conducted in 
accordance with the Code of Human Research Ethics of the British Psychological Society 
(British Psychological Society, 2014) and approved by a UK National Health Service Local 
Research Ethics Committee (Approval reference #12/SS/0133).  
 
Sample size 
The study by Ferreira et al. (in press), using self-help and a group workshop showed an effect 
size of .55 for the primary outcome of IBS Quality of Life.  The GLIMMPSE 
(http://glimmpse.samplesizeshop.org) software was used to calculate a sample size sufficient 
to detect equivalent effects (Guo, Logan, Glueck, & Muller, 2013). At an alpha of .05, 23 
participants would be needed to have 80% power to detect such effects. More conservatively, 
81 participants would have 80% power to detect effect sizes of .3 and above.  
 
Recruitment 
Recruitment took place between December 2014 and July 2015. Inclusion criteria were: 
Diagnosis of IBS, aged 18 years and older, and fluency in English. Exclusion criteria were: 
Women who were pregnant or breastfeeding, symptoms suggestive of inflammatory bowel 
disease (or similar), and inability to understand study consent procedure. These criteria were 
assessed by both the consultant gastroenterologist and the research assistant (author E.A.). 
Eligible patients met with the research assistant, who took written informed consent and 
administered pre-intervention measures. Some participants took the information sheets and 
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questionnaires away to consider involvement and were given prepaid postal envelopes to 
return assessment measures. Follow up measures were posted to participants at two and six 
months, along with a pre-paid return envelope. Participants were prompted by telephone to 
return questionnaires, when necessary. 
 
Intervention 
The intervention consisted of giving participants the self-help book “Better Living with IBS” 
(Ferreira & Gillanders, 2012) and the accompanying audio exercises on CD. The book 
contained information about IBS, stress and symptoms, exercises to reflect on use of control 
strategies, values exercises, and exercises to develop skills in mindfulness, defusion and 
willingness. Participants were encouraged to engage in the book, by their consultant in 
gastroenterology and by the research assistant. No specific protocol was used for this 
encouragement, instead the benefits of regular practice with the intervention were outlined. 
Participants were asked to work through the book at their own pace and they would likely 
complete all sections within the first two months. Participants received two telephone calls 
from the research assistant during the first and second months following recruitment. They 
typically lasted between five and 20 minutes and covered practical problems of engagement, 
clarification of information in the book, and encouragement to use the intervention strategies. 
All participants reported using the book and exercises at least to some degree, though this 
was not formally measured. 
 
Measures 
 
Demographic Variables 
At pre-treatment, information was collected on age, sex, marital status, education and 
duration of IBS symptoms.  
 
ROME III Questionnaire IBS Module (ROMEIII) 
 
The IBS module of the ROME III questionnaire (Longstreth et al., 2006) contains 10 
questions to aid diagnosis of IBS and determine subtype: Diarrhoea predominant, 
constipation predominant, mixed or unspecified.  
 
IBS36 Impact on Quality of Life Scale (IBS36)  
 
The primary outcome was the IBS36 (Groll et al., 2002). It is a 36-item measure of the 
impact of IBS on eating, social relationships, emotions, daily activities, school or 
employment, fatigue, sleep disturbance and sexual functioning. Higher scores represent 
greater impact of IBS on Quality of Life, i.e. worse functioning. Cronbach’s a in the current 
sample was .95. 
 
Visceral Sensitivity Index (VSI)  
 
A secondary outcome, the VSI measured gastrointestinal specific anxiety (Labus et al., 
2004). It has 15 items that assess cognitive and behavioural aspects of fear, anxiety and 
hypervigilance to gastrointestinal (GI) sensations. Higher scores represent greater GI specific 
anxiety. Cronbach’s a in the current sample was .92. 
 
IBS Symptom Severity Scale (IBS-SSS) 
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The IBS-SSS (Francis, Morris, & Whorwell, 1997) contains five items assessing pain 
severity, pain duration, bowel distension, satisfaction with bowel habit and impact on quality 
of life. The IBS-SSS was considered a secondary outcome. Cronbach’s a in the current 
sample was .82. 
 
IBS Acceptance and Action Questionnaire (IBS-AAQ)  
 
The IBS-AAQ is a 19-item measure of acceptance of IBS (Ferreira, Eugenicos, Morris, & 
Gillanders, 2012). It was considered a process measure. It contains two factors: Activity 
Engagement and IBS Willingness. Higher scores represent greater acceptance. Cronbach’s a 
in the current sample was .92 for the total scale, .89 for activity engagement and .89 for IBS 
willingness.  
 
IBS Behavioural Response Questionnaire (IBS-BRQ)  
 
The IBS-BRQ (Reme, Darnley, Kennedy, & Chalder, 2010) is a 26-item scale that assesses 
unhelpful behavioural responses to IBS, such as behaviours to control IBS, eating specific 
foods, avoiding certain foods, avoidance of normal activities, work, socialising, making 
plans, as well as repeated asking for reassurance, being hypervigilant to symptoms and the 
risk of bowel accidents etc. It was considered a further process measure. Cronbach’s a in the 
current sample was .90. 
 
Analytic Plan 
Data were analysed using SPSS version 20 (IBM corporation, 2011). Effect sizes and 
confidence intervals were calculated using the MBESS package for R (R Core Team, 2016; 
Kelley, 2016).  Data were tabulated by missing patterns and cases and visually assessed for 
missing data patterns. Histograms and distribution statistics were used to confirm parametric 
assumptions. Baseline data were examined between completers and those lost to follow up 
using independent t-tests and chi-square tests. Intervention effectiveness was analysed using 
repeated measures analysis of variance (rmANOVA) and further probed using t-tests. 
Completer status was examined as a significant moderator of response. As it was not 
significant for any variable, the data were presented without this covariate analysis. A related 
samples McNemar test was used to ascertain if the proportion of people no longer meeting 
diagnostic criteria following intervention was significant. 
 
Results 
 
Missing Data 
 
Within assessment phases there was no obvious pattern to missing data. Between phases 
however, if a participant did not provide data at post treatment they were also unlikely to 
provide it at follow up. In addition, completers had less severe IBS symptoms and higher 
levels of education at baseline. The data were considered missing at random (MAR), meaning 
that the probability of missing-ness is likely a function of other observed variables, though 
may not be a function of the missing data value itself (Enders, 2011). Following 
recommendations from Enders (2011), maximum likelihood estimation was used to impute 
missing data. It was chosen as it is easily implemented within SPSS, is a relatively 
conservative approach, and leads to similar estimates as more complex solutions such as 
multiple imputation (Enders, 2011).  
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Participants 
Seventy participants met eligibility criteria and were invited to enrol in the study, forty-five 
participants (64.2%) agreed to take part and provided data at baseline, with 36 (80%) 
completing measures at two months and 24 (53.3%) at six months.  
 
Parametric assumptions were met. Participants had been diagnosed with IBS for an average 
of ten years (Table 1). The ratio of females to males (87% female) is typical of the IBS 
population (e.g. Reme et al., 2010). Pre-treatment, two participants (4.4%) scored in the 
range of ‘Normal Bowel Function’, 11 (24.4%) reported ‘Mild IBS’, 21 (46.7%) reported 
‘Moderate IBS’, and 11 (24.4%) reported ‘Severe IBS’. At two months, two participants 
(4.4%) reported ‘Normal Bowel Function’, 20 (44.4%) reported ‘Mild IBS’, 13 (28.9%) 
reported ‘Moderate IBS’, and ten (22.2%) reported ‘Severe IBS’.  At six-months, four (8.9%) 
participants reported ‘Normal Bowel Function’, 16 (35.6%) reported ‘Mild IBS’, 15 (33.3%) 
reported ‘Moderate IBS’, and ten (22.2%) reported ‘Severe IBS’. A related samples marginal 
homogeneity test showed that these changes were not significant at two months (p = .07) or at 
six months (p = .10). 
 
Insert Table 1 here 
 
Treatment effects 
 
Table 2 shows the results of rmANOVA and t-tests. Contrary to prediction, participants did 
not show changes in the impact of IBS on quality of life. Participants did show improvements 
in GI specific anxiety, IBS symptom severity, and acceptance of IBS. The component of 
acceptance that reflected this change was the IBS willingness scale, and not activity 
engagement. Participants did not show significant changes in either activity engagement or in 
unhelpful behavioural responses to IBS, contrary to predictions. Finally, four (9%) 
participants no longer met criteria for an IBS diagnosis at Stage 3, though this change was not 
significant (Related samples McNemar test, c2(1) = 4, p = .13, ns).  
 
Insert Table 2 Here 
 
Discussion 
 
This study investigated ACT-based self-help for participants with treatment refractory IBS. 
Contrary to predictions, bibliotherapy did not reduce the impact of IBS on quality of life, the 
primary outcome measure. The intervention did lead to changes in IBS symptom severity, GI 
specific anxiety (secondary outcomes), and increased acceptance of IBS (process measure). 
That such changes occurred with minimal therapist contact is encouraging for the potential of 
this low-cost intervention to benefit many patients.  
 
Bibliotherapy did not however, lead to improvements in activity engagement or reduction of 
IBS avoidance behaviours. These were targets in the intervention, so it is concerning that 
they did not change. It is possible that further time and practice of acceptance, mindfulness 
and defusion skills were needed for these overt behaviours to be influenced. Bibliotherapy 
may have led to ‘acceptance’ as a change in stance or perspective on IBS, but not 
‘acceptance’ as a behavioural choice. It is possible that from this more willing stance, 
‘accepting behaviour’ may emerge, though given that participants were followed up at six 
months, this is considered less likely.  
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The current study built on the study of a workbook plus face to face group workshop 
intervention by Ferreira et al. (in press), by testing only the bibliotherapy component. Current 
results are comparable to the previous study in terms of improvements in symptom severity 
and acceptance, though the previous study produced improvements in the primary outcome of 
quality of life (d = .55).  The previous study also showed significant reductions in 
behavioural avoidance (d = .39). This could suggest that public commitment is required to 
produce overt behaviour changes.  The face to face study also produced larger reductions in 
GI specific anxiety (d = 1.1), suggesting that safely sharing IBS experiences is an important 
component. This could be considered a form of exposure.  
 
This is consistent with the studies by Ljótsson et al. (2010, 2011), which used therapist and 
peer support, greater structure and more explicit exposure to a variety of avoided situations. It 
could be that interpersonal contact, greater structure, more explicit focus on exposure or the 
combination of factors is required to create changes in behavioural avoidance and quality of 
life. A further dismantling study by Ljótsson et al. (2014) provided evidence that structured 
exposure strategies are indeed key to treatment success.   
 
There are several limitations to the current study. Firstly, the study is uncontrolled and it is 
possible that participants may have improved regardless of intervention. This interpretation is 
considered unlikely, given participants’ long histories of IBS. Changes could also be due to 
being in a trial per se, rather than due to engagement in the intervention. A further limitation 
concerns sampling bias. Participants were self-selected, which may limit generalisability. A 
further limitation concerns attrition. Forty-seven percent of participants were lost to follow 
up, the conservative assumption would be that these participants did not benefit. In addition, 
the sample size reduced the study’s power to detect smaller changes. Small samples can also 
lead to spurious non-null findings and to overestimation of the magnitude of effects (Button 
et al., 2013). Furthermore, underpowered studies can compound sampling biases that would 
be likely to be improved in a larger sample. This can lead to failures to replicate in future 
studies. 
 
Hunt et al. (2015), reported an attrition rate of 76%, making our study favourable in 
comparison, and comparable to Sanders et al. (2007). It is of note that except for Everitt et al. 
(2010), all self-help studies in IBS suffer from problems of high attrition. For the field to 
progress, explicit strategies need to be developed to retain participants, without undermining 
the minimal contact aspect of these interventions. In addition, future research could compare 
pure self-help versus guided self-help. 
 
Those lost to follow up scored higher for IBS symptom severity at baseline. It is possible that 
for those with more severe IBS, the bibliotherapy approach is not sufficient. A further 
limitation of the study is that we did not measure treatment fidelity / engagement. We 
therefore do not know the degree to which participants engaged in the approach and whether 
greater engagement lead to greater change. During telephone support, participants reported 
that they were using the intervention, though this was not formally measured.  
 
The effect sizes seen in the current study, and in other self-help for IBS studies, were modest. 
Notwithstanding, self-help interventions appear to be achieving similar effects as medications 
(Everitt et al., 2010). They are low cost and easily disseminated. Given that many patients 
have tried unsuccessfully to treat their IBS for an average of 10 years, it is our opinion that a 
modest effect size is worth pursuing.     
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The current study does represent a first step in testing ACT based self-help for IBS, and 
suggests a larger, better controlled trial is needed to address the limitations outlined. Future 
research could also incorporate economic analyses, and could assess mediation of treatment 
effects by changes in process variables, such as IBS willingness.  
 
Conclusions 
 
Bibliotherapy for people with refractory IBS led to changes in acceptance, symptom severity 
and GI anxiety, but not overt behaviour changes or improved quality of life. Confidence in 
these findings is provisional, given the limitations, though further study is warranted. 
 
 
Funding: This work was supported by the University of Edinburgh, College of Arts, 
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Table 1: Descriptives 
 
Variable Completers 
baseline 
n = 24 
Lost to follow up 
baseline 
n = 21 
c2(3) 
 Frequency Frequency 
 
 Female Male Female Male  
Sex 20 4 19 2 .65, ns 
Education   7.88* 
None 0 1  
Primary school 1 0  
Secondary school 3 10  
College / University 19 11  
Marital Status       1.08, ns 
Single  6 4  
Living as married 14 15  
Separated / Divorced 2 2  
Widowed 1 2  
IBS Subtype   3.4, ns 
Diarrhoea Predominant 6 6  
Constipation Predominant 6 8  
Mixed 3 0  
Unspecified 9 7  
 Mean (SD) Mean (SD) t(43) 
Age (years) 55.9 (10.4) 49.3 (14.9) 1.7, ns 
Duration of IBS (years) 11.1 (11.7) 9.4 (8.9) .56, ns 
IBS Symptom Severity 207.08 (97.6) 275.7 (114.2) 2.2* 
IBS36 Quality of Life Impact 84.1 (44.5) 105.6 (48.8) 1.5, ns 
IBS AAQ Total 57.4 (17.5) 51.1 (23.8) 1.0, ns 
IBS AAQ Activity Engagement  32.5 (9.3) 27.5 (12.9) 1.5, ns 
IBS AAQ Willingness 24.9 (10.6) 23.6 (13.1) .37, ns 
Visceral Sensitivity Index 38.8 (17.7) 45.2 (19.6) 1.2, ns 
IBS Behavioural Responses 
Questionnaire 87.1 (27.5) 97.9 (34.2) 1.2, ns 
*p<.05 
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Table 2: RmANOVA and t test analysis with maximum likelihood imputed missing data 
Variable Pre 
Intervention 
Mean 
(SD) 
2 month 
follow up 
Mean  
(SD) 
6 month 
follow up 
Mean  
(SD) 
F(2, 88) 
 
Effect  
Size 
(hp2)c 
(90% CI) 
Pre to 2 
months 
t(44) 
Effect  
size  
(d)d 
(95%CI) 
Pre to 6 
months 
t(1, 44) 
Effect 
 size  
(d) 
(95%CI) 
IBS36 Quality of Life 
Impact 
94.1 
(47.3) 
83.4 
(49.7) 
94.4 
(68.8) 1.2, ns 
.04 
(0 - .09) 1.7, ns 
.25 
(0 - .48) .04, ns 
.01 
0 - .20) 
Visceral Sensitivity Index 41.8 (18.7) 
34.6 
(14.2) 
40.4 
(23.4) 3.5
a* .07 (.01-.16) 2.8** 
.43 
(.11 - .73) .46, ns 
.07 
(0 - .34) 
IBS Symptom Severity 239.1 (110) 
202  
(122.6) 
206.2 
(124.8) 4.5
a* 
.09 
(.01-.18) 2.5* 
.38 
(.06 - .57) 2.2* 
.33 
(.02 - .53) 
IBS AAQ Total 54.5 (20.6) 
59.8 
(14.4) 
57.3 
(20.7) 4.0
a* .08 (.01-.17) 2.7** 
.46 
(.06 - .47) 1.3, ns 
.19 
(0 - .35) 
IBS AAQ Activity 
Engagement  
30.2 
(11.3) 
30.3 
(9.9) 
31.0 
(11.3) .44, ns 
.01 
(0 - .05) .15, ns 
.01 
(0 - .23) .82, ns 
.12 
(0 - .35) 
IBS AAQ Willingness 24.3 (11.7) 
29.5 
(7.0) 
26.4 
(11.9) 7.3
a*** 
.14 
.04 - .24) 3.8*** 
.65 
(.21 - .76) 1.3, ns 
.20 
(0 - .43) 
IBS Behavioural 
Responses Questionnaire 
92.1 
(30.9) 
84.1 
(34.6) 
94.0 
(38.8) 2.4, ns 
.05 
(0 - .13) 1.8, ns 
.26 
(0 - .53) .37, ns 
.06 
(0 - .34) 
Meets ROME III Criteria 45 / 45 100% 
41 / 45 
91% 
41/45 
91% 
c2(1) = 4, 
bp=.13, ns      
n = 45, *p<.05 **p<.01 *** p<.001 aGreenhouse-Geisser corrected bRelated samples McNemar Test, ceffect size conventions for hp2 are: small > .01, medium 
>.06 and large >.14 (Lackens, 2013), deffect size conventions for d are: small>.20, medium >.50, large >.80 (Cohen, 1992).  
